Testing a new eye drop for Sjögren's dry eye
Part of Bones, joints & muscles, Eyes & vision, Immune system & allergy, Mouth & dental, Skin clinical trials.
This trial tests a new eye drop made from a natural protein (rhPRG4) to see if it safely and effectively relieves dry eye symptoms in people with Sjögren's syndrome. You'll be randomly assigned to receive the study drop or a placebo (inactive) drop for several weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Sjögren's syndrome for at least 3 months.
- You are between 18 and 75 years old.
- You have moderate to severe dry eye symptoms (like dryness, burning, or grittiness).
- You are currently using only artificial tears for your dry eye (no other prescription drops like Restasis or Xiidra).
- You have not had any eye surgery or used other eye treatments (like steroid drops, IPL, or punctal plugs) in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental eye drop made from stem cells to see if it can help with the severe dry eye symptoms of Sjögren's syndrome. It might be an option if standard treatments like artificial tears haven't worked well for you.
This early-phase trial tests whether a new treatment using exosomes (tiny natural particles) given as eye drops or injections can help people with Sjögren's syndrome who have severe dry eyes that haven't responded to usual treatments. The goal is to see if it's safe and to get early hints of whether it relieves eye symptoms.
This study tests whether a new eye drop (rhPRG4) can safely reduce dry eye symptoms caused by graft-versus-host disease (GVHD). It compares the active drops to an inactive placebo to see if they provide better relief.
This study tests a new medicine called ICP-488 for people with primary Sjögren's syndrome. It may help reduce symptoms like dry eyes and dry mouth by calming the immune system. The trial lasts about 48 weeks and includes regular check-ups.
This study tests a new treatment for dry eye disease caused by Sjögren's syndrome. It may help people who still have dry eye symptoms even when using artificial tears.
This trial tests if using special eye drops (cyclosporine) along with tiny plugs placed in the tear ducts can improve dry eye symptoms in people with Sjögren's syndrome. The goal is to see if this combination works better than the drops alone.
Hear when a new Sjögren's Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.